✦ LIBER ✦

HCV selection and HVR1 evolution in a chimpanzee chronically infected with HCV-1 over 12 years

✍ Scribed by Ling Lu; Nakano Tatsunori; Chunhua Li; Sana Waheed; Fengxiang Gao; Betty H. Robertson

Book ID: 118087944
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 236 KB
Volume: 38
Category: Article
ISSN: 1386-6346
DOI: 10.1111/j.1872-034x.2008.00320.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retraction notice to “gC1qR expression i

Retraction notice to “gC1qR expression in chimpanzees with resolved and chronic infection: Potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection” [Virology 346 (2006) 324–327]

✍ Zhi Qiang Yao; Mohamed Tarek Shata; Nancy Tricoche; Mei Mei Shan; Betsy Brotman; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 69 KB

92 SAFETY, TOLERABILITY AND ANTIVIRAL AC

92 SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY OF VCH-916, A NOVEL NON-NUCLEOSIDE HCV POLYMERASE INHIBITOR IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION

✍ E. Lawitz; C. Cooper; M. Rodriguez-Torres; R. Ghalib; R. Lalonde; A. Sheikh; B. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Genetic complexity of the hypervariable

Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C

✍ Pawlotsky, Jean-Michel; Pellerin, Muriel; Bouvier, Magali; Roudot-Thoraval, Fran 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 3 views

A predictive model of treatment outcome

A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping

✍ Jose Ramón Vidal-Castiñeira; Antonio López-Vázquez; Rebeca Alonso-Arias; Marco A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 870 KB

2005 VIROLOGIC RESPONSE RATES FOLLOWING

2005 VIROLOGIC RESPONSE RATES FOLLOWING 4 WEEKS OF FILIBUVIR IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONICALLY-INFECTED HCV GENOTYPE-1 PATIENTS

✍ Jacobson, I.; Pockros, P.J.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJ 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Significance of a reduction in HCV RNA l

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin

✍ Hidenori Toyoda, Takashi Kumada, Noritomo Shimada… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 210 KB